{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"8"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"9"}],"units":"Participants"}],"groups":[{"description":"Ribociclib administered orally; daily on days 1-21 each 28 day cycle; dose calculation age dependent (\\>21 yrs of age 600mg daily (DIPG); \\<21 yrs of age 350 mg/m2/day)\n\nRibociclib","id":"OG000","title":"RB+ High Grade Glioma"},{"description":"Ribociclib administered orally; daily on days 1-21 each 28 day cycle; dose calculation age dependent (\\>21 yrs of age 600mg daily (DIPG); \\<21 yrs of age 350 mg/m2/day)\n\nRibociclib","id":"OG001","title":"Non-Biopsied Diffuse Instrinsic Pontine Glioma"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Number of enrolled and evaluable participants","reportingStatus":"POSTED","timeFrame":"1 year","title":"Number of Patients Alive at One Year","type":"PRIMARY","unitOfMeasure":"Participants"}